Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis

Saved in:
Bibliographic Details
Published in:Romanian Journal of Anaesthesia and Intensive Care
Format: Online Article RSS Article
Published: 2023
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864030188060278788
collection WordPress RSS
FRELIP Feed Integration
container_title Romanian Journal of Anaesthesia and Intensive Care
description
discipline_display Medical & Health Sciences
discipline_facet Medical & Health Sciences
format Online Article
RSS Article
genre Journal Article
id rss_article:35618
institution FRELIP
journal_source_facet Romanian Journal of Anaesthesia and Intensive Care
publishDate 2023
publishDateSort 2023
record_format rss_article
spellingShingle Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis
— — — — — — Anaesthesiology
Clinical Medicine
Medical & Health Sciences
sub_discipline_display Clinical Medicine
sub_discipline_facet Clinical Medicine
subject_display — — — — — — Anaesthesiology
Clinical Medicine
Medical & Health Sciences
— — — — — — Anaesthesiology
Clinical Medicine
Medical & Health Sciences
subject_facet — — — — — — Anaesthesiology
Clinical Medicine
Medical & Health Sciences
title Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis
title_auth Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis
title_full Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis
title_fullStr Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis
title_full_unstemmed Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis
title_short Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis
title_sort effect of tocilizumab on “ventilator free days” composite outcome in sars-cov-2 patients: a retrospective competing risk analysis
topic — — — — — — Anaesthesiology
Clinical Medicine
Medical & Health Sciences
url https://sciendo.com/article/10.2478/rjaic-2022-0001